Pitt, UPMC Announce $200 Million Immunotherapy Investment

February 13, 2018

Pitt and UPMC leaders today announced plans to establish the new UPMC Immune Transplant and Therapy Center (ITTC).

As part of the collaboration, UPMC has made a $200 million commitment to ITTC, and the University will transform a century-old building at 5000 Baum Boulevard into a world-class space for labs, offices, startup companies, and industry partners.

5000 Baum represents the University’s most significant contribution thus far to strengthening a regional innovation district aimed at spurring jobs and economic growth in western Pennsylvania.

“Today opens an exciting new chapter in our ability to partner with others to advance the University of Pittsburgh’s mission of using knowledge for society’s gain,” said Pitt Chancellor Patrick Gallagher. “We are creating an unprecedented ecosystem—one that connects basic science discoveries from Pitt with life-changing advances from UPMC while leveraging the catalytic power of industry partners. It’s a combination that will transform immunotherapy care and help us tackle some of medicine’s greatest challenges.”


Read More


Additional Resources:


Pittsburgh Business Times